Graft vs Host Disease: Novel Management Strategies for a Chronic Condition

Target Audience
The intended audience for this activity is transplant specialists, oncologists, hematologists, and other healthcare professionals involved in the treatment of patients with GVHD.

Program Overview
This enduring activity takes learners on a compelling journey in managing chronic graft-versus-host disease (cGVHD) by explaining the evidence-based diagnostic criteria for cGVHD for prompt diagnosis; discussing the clinical safety and efficacy data of recently approved and investigational therapeutic agents, and finally, developing strategies to create treatment plans that address the psychosocial impact of disease and prioritize improvement in quality of life. Learners are invited to explore challenging aspects of this condition with the goal of informing selection of the most appropriate treatment regimens targeting disease etiopathogenesis. This immersive experience highlights the importance of early recognition in the effective management of cGVHD.

Learning Objectives
After completing the CME activity, learners should be better able to:

Explain the evidence-based diagnostic criteria for chronic GVHD for prompt diagnosis
Discuss the clinical safety and efficacy data of recently approved and investigational therapeutic agents
Develop strategies to create treatment plans that include considerations for improvements in quality of life and psychosocial impact of disease